secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0000950170-23-053752
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics director Dr. John Baldoni resigns effective Oct 31, 2023
--------------------------------------------------------------------------

- Dr. John Baldoni resigns from board effective Oct 31, 2023, citing manufacturing advancements reducing need for his technical contributions.
- He will serve as ad hoc technical advisor to the Company following his departure.
- Baldoni did not step down due to any disagreement with MiNK's operations, policies, or practices.
- Notice of resignation was sent on October 12, 2023; effective October 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/0000950170-23-053752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/inkt-20231012.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-053752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer